Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Astellas Engineered Small Molecules U.K. Limited
Astellas Engineered Small Molecules U.K. Limited is an active company incorporated on 12 December 2012 with the registered office located in Cambridge, Cambridgeshire. Astellas Engineered Small Molecules U.K. Limited was registered 12 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
08328823
Private limited company
Age
12 years
Incorporated
12 December 2012
Size
Unreported
Confirmation
Submitted
Dated
5 November 2024
(10 months ago)
Next confirmation dated
5 November 2025
Due by
19 November 2025
(2 months remaining)
Last change occurred
1 year 10 months ago
Accounts
Submitted
For period
1 Apr
⟶
31 Mar 2024
(1 year)
Accounts type is
Full
Next accounts for period
31 March 2025
Due by
31 December 2025
(3 months remaining)
Learn more about Astellas Engineered Small Molecules U.K. Limited
Contact
Address
Merrifield Centre
Rosemary Lane
Cambridge
CB1 3LQ
Same address for the past
11 years
Companies in CB1 3LQ
Telephone
01223423506
Email
Available in Endole App
Website
Bactevo.com
See All Contacts
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Mrs Lesley ANN Flowerdew
Director • Chartered Accountant • British • Lives in England • Born in Oct 1967
Dr David Barrett
Director • British • Lives in England • Born in Jan 1962
Astellas Pharma Europe Ltd
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
No mutual companies found
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Period Ended
31 Mar 2024
For period
31 Mar
⟶
31 Mar 2024
Traded for
12 months
Cash in Bank
Unreported
Decreased by £1.26M (-100%)
Turnover
Unreported
Same as previous period
Employees
19
Same as previous period
Total Assets
£10.43M
Decreased by £137K (-1%)
Total Liabilities
-£2.24M
Decreased by £7.45M (-77%)
Net Assets
£8.19M
Increased by £7.32M (+838%)
Debt Ratio (%)
21%
Decreased by 70.3% (-77%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
8 Months Ago on 30 Dec 2024
Confirmation Submitted
9 Months Ago on 15 Nov 2024
Amended Full Accounts Submitted
1 Year 2 Months Ago on 8 Jul 2024
Amended Full Accounts Submitted
1 Year 2 Months Ago on 8 Jul 2024
Amended Full Accounts Submitted
1 Year 2 Months Ago on 8 Jul 2024
Confirmation Submitted
1 Year 10 Months Ago on 7 Nov 2023
Full Accounts Submitted
1 Year 10 Months Ago on 18 Oct 2023
Full Accounts Submitted
2 Years 9 Months Ago on 23 Nov 2022
Confirmation Submitted
2 Years 10 Months Ago on 7 Nov 2022
Yoshitsugu Shitaka Resigned
3 Years Ago on 24 Aug 2022
Get Alerts
Get Credit Report
Discover Astellas Engineered Small Molecules U.K. Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Statement of capital following an allotment of shares on 27 January 2025
Submitted on 28 Jan 2025
Full accounts made up to 31 March 2024
Submitted on 30 Dec 2024
Second filing of Confirmation Statement dated 5 November 2024
Submitted on 20 Nov 2024
Confirmation statement made on 5 November 2024 with no updates
Submitted on 15 Nov 2024
Second filing of a statement of capital following an allotment of shares on 23 November 2023
Submitted on 1 Oct 2024
Statement of capital following an allotment of shares on 20 May 2024
Submitted on 30 Sep 2024
Second filing of a statement of capital following an allotment of shares on 14 April 2023
Submitted on 29 Sep 2024
Second filing of a statement of capital following an allotment of shares on 17 July 2023
Submitted on 29 Sep 2024
Second filing of a statement of capital following an allotment of shares on 25 April 2022
Submitted on 29 Sep 2024
Second filing of a statement of capital following an allotment of shares on 17 July 2023
Submitted on 28 Sep 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs